Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · IEX Real-Time Price · USD
58.00
+4.97 (9.37%)
At close: Jul 19, 2024, 4:00 PM
59.50
+1.50 (2.59%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
CRBP Market Cap
CRBP has a market cap or net worth of $619.83 million as of July 22, 2024. Its market cap has increased by 1,818.97% in one year.
Market Cap
619.83M
Enterprise Value
516.34M
1-Year Change
1,818.97%
Ranking
Category
Stock Price
$58.00
Market Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $619.83M, an increase of 717.72%. That is a compound annual growth rate of 24.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 619.80M | 2,221.35% |
| Dec 29, 2023 | 26.70M | 93.48% |
| Dec 30, 2022 | 13.80M | -82.10% |
| Dec 31, 2021 | 77.10M | -26.57% |
| Dec 31, 2020 | 105.00M | -70.26% |
| Dec 31, 2019 | 353.10M | 5.62% |
| Dec 31, 2018 | 334.30M | -14.19% |
| Dec 29, 2017 | 389.60M | 3.75% |
| Dec 30, 2016 | 375.50M | 505.65% |
| Dec 31, 2015 | 62.00M | -19.58% |
| Dec 31, 2014 | 77.10M | 1.72% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PetIQ | 630.85M |
| Entrada Therapeutics | 630.40M |
| ArriVent BioPharma | 628.68M |
| Ginkgo Bioworks Holdings | 624.97M |
| KalVista Pharmaceuticals | 621.80M |
| REGENXBIO | 619.64M |
| Astria Therapeutics | 615.03M |
| Replimune Group | 607.40M |